Author

Felai Tan

Institution: Onconova Therapeutics (United States)

Observed institutions: Onconova Therapeutics (United States), Presage Biosciences (United States)

OpenAlex ID: A5069680841

Characterization of LP-118, a Novel Small Molecule Inhibitor of Bcl-2 and Bcl-Xl in Chronic Lymphocytic Leukemia Resistant to Venetoclax

2021 · Janani Ravikrishnan, Elizabeth M. Muhowski, et al. · Blood · 10

LP-118, a Novel BCL2 Inhibitor, Shows Potent in Vitro Anti-Myeloma Activity

2022 · Rodrigo Fonseca, Yuan Xiao Zhu, et al. · Blood · 2

LP-118, a Selective Bcl-2 Inhibitor with Tuned Bcl-Xl Activity, Causes Myeloid Differentiation and Cell Death in Acute Myeloid Leukemia (AML)

2022 · Kristin L Koenig, Colin Brame, et al. · Blood

Targeting Apoptosis with Novel BH3 Mimetics in T-Lineage Acute Lymphoblastic Leukemia

2022 · Caner Saygin, Bartholomew Eisfelder, et al. · Blood

Works count: 4

Citation count: 12

H-index: 2

I10-index: 1